Cargando…

Leverage biomaterials to modulate immunity for type 1 diabetes

The pathogeny of type 1 diabetes (T1D) is mainly provoked by the β-cell loss due to the autoimmune attack. Critically, autoreactive T cells firsthand attack β-cell in islet, that results in the deficiency of insulin in bloodstream and ultimately leads to hyperglycemia. Hence, modulating immunity to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jing, Zhangyan, Li, Yuan, Ma, Yumeng, Zhang, Xiaozhou, Liang, Xin, Zhang, Xudong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667795/ https://www.ncbi.nlm.nih.gov/pubmed/36405706 http://dx.doi.org/10.3389/fimmu.2022.997287

Ejemplares similares

Diversity of immune checkpoints in cancer immunotherapy
por: Guo, Zhangyan, et al.
Publicado: (2023)

Immune Modulation by Transplanted Calcium Phosphate Biomaterials and Human Mesenchymal Stromal Cells in Bone Regeneration
por: Humbert, Paul, et al.
Publicado: (2019)

Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice
por: Wu, Chengfei, et al.
Publicado: (2019)

Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy
por: Wei, Qi, et al.
Publicado: (2022)

Material matters: exploring the interplay between natural biomaterials and host immune system
por: Tripathi, Alok Shiomurti, et al.
Publicado: (2023)

Intestinal Bacteria Encapsulated by Biomaterials Enhance Immunotherapy
por: Liu, Yilun, et al.
Publicado: (2021)

Leveraging Antibody, B Cell and Fc Receptor Interactions to Understand Heterogeneous Immune Responses in Tuberculosis
por: Carpenter, Stephen M., et al.
Publicado: (2022)

Overcoming the immune suppressive nature of glioblastoma by leveraging the surgical intervention - current status and future perspectives
por: Duerinck, Johnny, et al.
Publicado: (2023)

Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes
por: Stojanović, Ivana, et al.
Publicado: (2021)

Biomaterials-Based Modulation of the Immune System
por: Gardner, Austin B., et al.
Publicado: (2013)

Biomaterials promote in vivo generation and immunotherapy of CAR-T cells
por: Qin, Ya-Ting, et al.
Publicado: (2023)

Tailoring biomaterials and applications targeting tumor-associated macrophages in cancers
por: Jing, Fangqi, et al.
Publicado: (2022)

Cholinergic Modulation of Type 2 Immune Responses
por: Bosmans, Goele, et al.
Publicado: (2017)

Activation of Bone Marrow Adaptive Immunity in Type 2 Diabetes: Rescue by Co-stimulation Modulator Abatacept
por: Santopaolo, Marianna, et al.
Publicado: (2021)

IL-10 Deficiency Accelerates Type 1 Diabetes Development via Modulation of Innate and Adaptive Immune Cells and Gut Microbiota in BDC2.5 NOD Mice
por: Huang, Juan, et al.
Publicado: (2021)

Leveraging Genetic Findings for Precision Medicine in Vasculitis
por: Acosta-Herrera, Marialbert, et al.
Publicado: (2019)

Micronized Acellular Matrix Biomaterial Leverages Eosinophils for Postinfarct Cardiac Repair
por: Vasanthan, Vishnu, et al.
Publicado: (2023)

Rational Design of Antigen Incorporation Into Subunit Vaccine Biomaterials Can Enhance Antigen-Specific Immune Responses
por: Tsoras, Alexandra N., et al.
Publicado: (2020)

Impact of Drp1-Mediated Mitochondrial Dynamics on T Cell Immune Modulation
por: Song, Jun, et al.
Publicado: (2022)

Schistosoma Infection and Schistosoma-Derived Products Modulate the Immune Responses Associated with Protection against Type 2 Diabetes
por: Tang, Chun-Lian, et al.
Publicado: (2018)

Adipose Tissue-Resident Immune Cells in Obesity and Type 2 Diabetes
por: Lu, Jingli, et al.
Publicado: (2019)

Leveraging NKG2D Ligands in Immuno-Oncology
por: Fuertes, Mercedes Beatriz, et al.
Publicado: (2021)

Biomaterials in orthopaedics: the past and future with immune modulation
por: Im, Gun-Il
Publicado: (2020)

Leveraging Biomaterial Mechanics to Improve Pluripotent Stem Cell Applications for Tissue Engineering
por: Lenzini, Stephen, et al.
Publicado: (2019)

Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells
por: Schluck, Marjolein, et al.
Publicado: (2019)

Immune checkpoint inhibitors-related pancreatitis with fulminant type 1 diabetes mellitus: case report and literature review
por: Fang, Wei, et al.
Publicado: (2023)

Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications
por: Zhang, Jing, et al.
Publicado: (2022)

Construction and validation of an angiogenesis-related scoring model to predict prognosis, tumor immune microenvironment and therapeutic response in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2022)

Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients
por: Chen, Hualin, et al.
Publicado: (2023)

Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response in vivo
por: Ma, Shining, et al.
Publicado: (2023)

Intestinal Epithelial Cell Regulation of Adaptive Immune Dysfunction in Human Type 1 Diabetes
por: Graves, Christina L., et al.
Publicado: (2017)

The m6A methylation profiles of immune cells in type 1 diabetes mellitus
por: Wang, Yimeng, et al.
Publicado: (2022)

Monitoring islet specific immune responses in type 1 diabetes clinical immunotherapy trials
por: Arif, Sefina, et al.
Publicado: (2023)

The Effect of Immunosuppressive Adjuvant Kynurenine on Type 1 Diabetes Vaccine
por: Sun, Jing, et al.
Publicado: (2021)

Modulation of Immunity by Lymphatic Dysfunction in Lymphedema
por: Yuan, Yinan, et al.
Publicado: (2019)

Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes
por: Ding, Qiyou, et al.
Publicado: (2022)

Clostridium butyricum CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells
por: Jia, Lingling, et al.
Publicado: (2017)

Epigenetic modulation of type-1 diabetes via a dual effect on pancreatic macrophages and β cells
por: Fu, Wenxian, et al.
Publicado: (2014)

A Deeper Look into Type 1 Diabetes – Imaging Immune Responses during Onset of Disease
por: Christoffersson, Gustaf, et al.
Publicado: (2016)

Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study
por: Speake, Cate, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i18f4k5iju2ll33behg3ppa7ju